New insight on FGFR3-related chondrodysplasias molecular physiopathology revealed by human chondrocyte gene expression profiling

PLoS ONE

Volumn 4, Issue 10, 2009, Pages

  Schibler, Laurent ^a,b   Gibbs, Linda ^a,c   Benoist Lasselin, Catherine ^a   Decraene, Charles ^d   Martinovic, Jelena ^e   Loget, Philippe ^f   Delezoide, Anne Lise ^g   Gonzales, Marie ^h   Munnich, Arnold ^a   Jais, Jean Philippe ^e   Legeai Mallet, Laurence ^a  

^a INSERM   (France)

^b UMR1313 GÉNÉTIQUE ANIMALE ET BIOLOGIE INTÉGRATIVE   (France)

^c 4Clinics ^*  (Belgium)

^d INSTITUT CURIE   (France)

^e HÔPITAL NECKER ENFANTS MALADES   (France)

^f Service d'urologie Université et hôpital de Rennes   (France)

^g HÔPITAL ROBERT DEBRÉ   (France)

^h ARMAND TROUSSEAU HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 3; GLYCOSAMINOGLYCAN; PROTEOGLYCAN; FGFR3 PROTEIN, HUMAN;

ARTICLE; CARTILAGE CELL; CELL ADHESION; CELL CYCLE PROGRESSION; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL GROWTH; CELL ISOLATION; CELL METABOLISM; CELL MOTILITY; CELL PROLIFERATION; CELL TYPE; CHONDRODYSPLASIA; CONTROLLED STUDY; CYTOKINESIS; DNA SYNTHESIS; DOWN REGULATION; EXTRACELLULAR MATRIX; FETUS; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE MUTATION; HUMAN; HUMAN CELL; HUMAN TISSUE; PATHOPHYSIOLOGY; PROTEIN SYNTHESIS; SIGNAL TRANSDUCTION; SPINDLE CELL; SULFATION; THANATOPHORIC DWARFISM; CARTILAGE; CYTOLOGY; DNA MICROARRAY; GENETICS; HEREDITARY MULTIPLE EXOSTOSIS; HETEROZYGOTE; METABOLISM; MUTATION; PRENATAL DEVELOPMENT; PROMOTER REGION; QUALITY CONTROL;

CARTILAGE; CELL PROLIFERATION; CHONDROCYTES; EXOSTOSES, MULTIPLE HEREDITARY; EXTRACELLULAR MATRIX; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HETEROZYGOTE; HUMANS; MUTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROMOTER REGIONS, GENETIC; PROTEOGLYCANS; QUALITY CONTROL; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 3; SIGNAL TRANSDUCTION;

EID: 70449597890     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0007633     Document Type: Article

References (69)

1. Minina E, Wenzel HM, Kreschel C, Karp S, Gaffield W, et al. (2001) BMP and hh/PTHrP signaling interact to coordinate chondrocyte proliferation and differentiation. Development 128: 4523-4534.
2. Teixeira CC, Agoston H, Beier F (2008) Nitric oxide, C-type natriuretic peptide and cGMP as regulators of endochondral ossification. Dev Biol 319: 171-178.
3. Yasoda A, Komatsu Y, Chusho H, Miyazawa T, Ozasa A, et al. (2004) Overexpression of CNP in chondrocytes rescues achondroplasia through a MAPK-dependent pathway. Nat Med 10: 80-86.
4. Adams SL, Cohen AJ, Lassova L (2007) Integration of signaling pathways regulating chondrocyte differentiation during endochondral bone formation. J Cell Physiol 213: 635-641.
5. Pejchalova K, Krejci P, Wilcox WR (2007) C-natriuretic peptide: an important regulator of cartilage. Mol Genet Metab 92: 210-215.
6. Wan M, Cao X (2005) BMP signaling in skeletal development. Biochem Biophys Res Commun 328: 651-657.
7. Lai LP, Mitchell J (2005) Indian hedgehog: its roles and regulation in endochondral bone development. J Cell Biochem 96: 1163-1173.
8. Ornitz DM (2005) FGF signaling in the developing endochondral skeleton. Cytokine Growth Factor Rev 16: 205-213.
9. Aszodi A, Hunziker EB, Brakebusch C, Fassler R (2003) Beta1 integrins regulate chondrocyte rotation, G1 progression, and cytokinesis. Genes Dev 17: 2465-2479.
10. Serra R (2008) Role of intraflagellar transport and primary cilia in skeletal development. Anat Rec (Hoboken) 291: 1049-1061.
11. Labrador JP, Azcoitia V, Tuckermann J, Lin C, Olaso E, et al. (2001) The collagen receptor DDR2 regulates proliferation and its elimination leads to dwarfism. EMBO Rep 2: 446-452.
12. Wang W, Kirsch T (2006) Annexin V/beta5 integrin interactions regulate apoptosis of growth plate chondrocytes. J Biol Chem 281: 30848-30856.
13. Grashoff C, Aszodi A, Sakai T, Hunziker EB, Fassler R (2003) Integrin-linked kinase regulates chondrocyte shape and proliferation. EMBO Rep 4: 432-438.
14. Woods A, Wang G, Beier F (2007) Regulation of chondrocyte differentiation by the actin cytoskeleton and adhesive interactions. J Cell Physiol 213: 1-8.
15. Woods A, James CG, Wang G, Dupuis H, Beier F (2009) Control of Chondrocyte Gene Expression by Actin Dynamics: A Novel Role of Cholesterol/Roralpha Signaling in Endochondral Bone Growth. J Cell Mol Med.
16. Kobayashi T, Kronenberg H (2005) Minireview: transcriptional regulation in development of bone. Endocrinology 146: 1012-1017.
17. Solomon LA, Berube NG, Beier F (2008) Transcriptional regulators of chondrocyte hypertrophy. Birth Defects Res C Embryo Today 84: 123-130.
18. Provot S, Kempf H, Murtaugh LC, Chung UI, Kim DW, et al. (2006) Nkx3.2/ Bapx1 acts as a negative regulator of chondrocyte maturation. Development 133: 651-662.
19. de Frutos CA, Vega S, Manzanares M, Flores JM, Huertas H, et al. (2007) Snail1 is a transcriptional effector of FGFR3 signaling during chondrogenesis and achondroplasias. Dev Cell 13: 872-883.
20. Tare RS, Townsend PA, Packham GK, Inglis S, Oreffo RO (2008) Bcl-2-associated athanogene-1 (BAG-1): a transcriptional regulator mediating chondrocyte survival and differentiation during endochondral ossification. Bone 42: 113-128.
21. Rousseau F, Bonaventure J, Legeai-Mallet L, Pelet A, Rozet JM, et al. (1994) Mutations in the gene encoding fibroblast growth factor receptor-3 in achondroplasia. Nature 371: 252-254.
22. Rousseau F, el Ghouzzi V, Delezoide AL, Legeai-Mallet L, Le Merrer M, et al. (1996) Missense FGFR3 mutations create cysteine residues in thanatophoric dwarfism type I (TD1). Hum Mol Genet 5: 509-512.
23. Webster MK, Donoghue DJ (1997) FGFR activation in skeletal disorders: too much of a good thing. Trends Genet 13: 178-182.
24. L'Hote CG, Knowles MA (2005) Cell responses to FGFR3 signalling: growth, differentiation and apoptosis. Exp Cell Res 304: 417-431.
25. Legeai-Mallet L, Benoist-Lasselin C, Munnich A, Bonaventure J (2004) Overexpression of FGFR3, Stat1, Stat5 and p21Cip1 correlates with phenotypic severity and defective chondrocyte differentiation in FGFR3-related chondrodysplasias. Bone 34: 26-36.
26. Sahni M, Ambrosetti DC, Mansukhani A, Gertner R, Levy D, et al. (1999) FGF signaling inhibits chondrocyte proliferation and regulates bone development through the STAT-1 pathway. Genes Dev 13: 1361-1366.
27. Sahni M, Raz R, Coffin JD, Levy D, Basilico C (2001) STAT1 mediates the increased apoptosis and reduced chondrocyte proliferation in mice overexpressing FGF2. Development 128: 2119-2129.
28. Meyer AN, Gastwirt RF, Schlaepfer DD, Donoghue DJ (2004) The cytoplasmic tyrosine kinase Pyk2 as a novel effector of fibroblast growth factor receptor 3 activation. J Biol Chem 279: 28450-28457.
29. Murakami S, Balmes G, McKinney S, Zhang Z, Givol D, et al. (2004) Constitutive activation of MEK1 in chondrocytes causes Stat1-independent achondroplasia-like dwarfism and rescues the Fgfr3-deficient mouse phenotype. Genes Dev 18: 290-305.
30. Nowroozi N, Raffioni S, Wang T, Apostol BL, Bradshaw RA, et al. (2005) Sustained ERK1/2 but not STAT1 or 3 activation is required for thanatophoric dysplasia phenotypes in PC12 cells. Hum Mol Genet 14: 1529-1538.
31. Ozasa A, Komatsu Y, Yasoda A, Miura M, Sakuma Y, et al. (2005) Complementary antagonistic actions between C-type natriuretic peptide and the MAPK pathway through FGFR-3 in ATDC5 cells. Bone 36: 1056-1064.
32. Rozenblatt-Rosen O, Mosonego-Ornan E, Sadot E, Madar-Shapiro L, Sheinin Y, et al. (2002) Induction of chondrocyte growth arrest by FGF: transcriptional and cytoskeletal alterations. J Cell Sci 115: 553-562.
33. Priore R, Dailey L, Basilico C (2006) Downregulation of Akt activity contributes to the growth arrest induced by FGF in chondrocytes. J Cell Physiol 207: 800-808.
34. Aikawa T, Segre GV, Lee K (2001) Fibroblast growth factor inhibits chondrocytic growth through induction of p21 and subsequent inactivation of cyclin E-Cdk2. J Biol Chem 276: 29347-29352.
35. Laplantine E, Rossi F, Sahni M, Basilico C, Cobrinik D (2002) FGF signaling targets the pRb-related p107 and p130 proteins to induce chondrocyte growth arrest. J Cell Biol 158: 741-750.
36. Dailey L, Laplantine E, Priore R, Basilico C (2003) A network of transcriptional and signaling events is activated by FGF to induce chondrocyte growth arrest and differentiation. J Cell Biol 161: 1053-1066.
37. Burgess WH, Maciag T (1989) The heparin-binding (fibroblast) growth factor family of proteins. Annu Rev Biochem 58: 575-606.
38. Cheung AK, Lung HL, Hung SC, Law EW, Cheng Y, et al. (2008) Functional analysis of a cell cycle-associated, tumor-suppressive gene, protein tyrosine phosphatase receptor type G, in nasopharyngeal carcinoma. Cancer Res 68: 8137-8145.
39. Moon NS, Dyson N (2008) E2F7 and E2F8 keep the E2F family in balance. Dev Cell 14: 1-3.
40. Itano N, Sawai T, Yoshida M, Lenas P, Yamada Y, et al. (1999) Three Isoforms of Mammalian Hyaluronan Synthases Have Distinct Enzymatic Properties. J Biol Chem 274: 25085-25092.
41. Forlino A, Piazza R, Tiveron C, Della Torre S, Tatangelo L, et al. (2005) A diastrophic dysplasia sulfate transporter (SLC26A2) mutant mouse: morphological and biochemical characterization of the resulting chondrodysplasia phenotype. Hum Mol Genet 14: 859-871.
42. Frederick JP, Tafari AT, Wu SM, Megosh LC, Chiou ST, et al. (2008) A role for a lithium-inhibited Golgi nucleotidase in skeletal development and sulfation. Proc Natl Acad Sci U S A 105: 11605-11612.
43. Settembre C, Arteaga-Solis E, McKee MD, de Pablo R, Al Awqati Q, et al. (2008) Proteoglycan desulfation determines the efficiency of chondrocyte autophagy and the extent of FGF signaling during endochondral ossification. Genes Dev 22: 2645-2650.
44. Kurima K, Warman ML, Krishnan S, Domowicz M, Krueger RC Jr, et al. (1998) A member of a family of sulfate-activating enzymes causes murine brachymorphism. Proc Natl Acad Sci U S A 95: 8681-8685.
45. Wang G, Woods A, Agoston H, Ulici V, Glogauer M, et al. (2007) Genetic ablation of Rac1 in cartilage results in chondrodysplasia. Dev Biol 306: 612-623.
46. Morales TI (2007) Chondrocyte moves: clever strategies? Osteoarthritis Cartilage 15: 861-871.
47. Ambrosino C, Mace G, Galban S, Fritsch C, Vintersten K, et al. (2003) Negative feedback regulation of MKK6 mRNA stability by p38alpha mitogen-activated protein kinase. Mol Cell Biol 23: 370-381.
48. Raucci A, Laplantine E, Mansukhani A, Basilico C (2004) Activation of the ERK1/2 and p38 mitogen-activated protein kinase pathways mediates fibroblast growth factor-induced growth arrest of chondrocytes. J Biol Chem 279: 1747-1756.
49. Li C, Scott DA, Hatch E, Tian X, Mansour SL (2007) Dusp6 (Mkp3) is a negative feedback regulator of FGF-stimulated ERK signaling during mouse development. Development 134: 167-176.
50. Wang IC, Chen YJ, Hughes DE, Ackerson T, Major ML, et al. (2008) FoxM1 regulates transcription of JNK1 to promote the G1/S transition and tumor cell invasiveness. J Biol Chem 283: 20770-20778.
51. Zorn AM (2001) Wnt signalling: antagonistic Dickkopfs. Curr Biol 11: R592-595.
52. Chuang PT, McMahon AP (1999) Vertebrate Hedgehog signalling modulated by induction of a Hedgehog-binding protein. Nature 397: 617-621.
53. Eggenschwiler JT, Bulgakov OV, Qin J, Li T, Anderson KV (2006) Mouse Rab23 regulates hedgehog signaling from smoothened to Gli proteins. Dev Biol 290: 1-12.
54. Park M, Yong Y, Choi SW, Kim JH, Lee JE, et al. (2007) Constitutive RelA activation mediated by Nkx3.2 controls chondrocyte viability. Nat Cell Biol 9: 287-298.
55. Bumeister R, Rosse C, Anselmo A, Camonis J, White MA (2004) CNK2 couples NGF signal propagation to multiple regulatory cascades driving cell differentiation. Curr Biol 14: 439-445.
56. Nojima H, Adachi M, Matsui T, Okawa K, Tsukita S (2008) IQGAP3 regulates cell proliferation through the Ras/ERK signalling cascade. Nat Cell Biol 10: 971-978.
57. Dhanasekaran DN, Kashef K, Lee CM, Xu H, Reddy EP (2007) Scaffold proteins of MAP-kinase modules. Oncogene 26: 3185-3202.
58. Harrison RE, Sikorski BA, Jongstra J (2004) Leukocyte-specific protein 1 targets the ERK/MAP kinase scaffold protein KSR and MEK1 and ERK2 to the actin cytoskeleton. J Cell Sci 117: 2151-2157.
59. Karreth F, Hoebertz A, Scheuch H, Eferl R, Wagner EF (2004) The AP1 transcription factor Fra2 is required for efficient cartilage development. Development 131: 5717-5725.
60. Tsumaki N, Yoshikawa H (2005) The role of bone morphogenetic proteins in endochondral bone formation. Cytokine Growth Factor Rev 16: 279-285.
61. Greene LA, Lee HY, Angelastro JM (2009) The transcription factor ATF5: role in neurodevelopment and neural tumors. J Neurochem 108: 11-22.
62. Wu S, Flint JK, Rezvani G, De Luca F (2007) Nuclear factor-kappaB p65 facilitates longitudinal bone growth by inducing growth plate chondrocyte proliferation and differentiation and by preventing apoptosis. J Biol Chem 282: 33698-33706.
63. Legeai-Mallet L, Benoist-Lasselin C, Delezoide AL, Munnich A, Bonaventure J (1998) Fibroblast growth factor receptor 3 mutations promote apoptosis but do not alter chondrocyte proliferation in thanatophoric dysplasia. J Biol Chem 273: 13007-13014.
64. Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, et al. (2004) Bioconductor: open software development for computational biology and bioinformatics. Genome Biol 5: R80.
65. Smyth GK (2005) Limma: linear models for microarray data. Bioinformatics and Computational Biology Solutions using R and Bioconductor: Springer, New York. pp 397-420.
66. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J (2007) qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 8: R19.
67. Pombo-Suarez M, Calaza M, Gomez-Reino JJ, Gonzalez A (2008) Reference genes for normalization of gene expression studies in human osteoarthritic articular cartilage. BMC Mol Biol 9: 17.
68. Benoist-Lasselin C, Gibbs L, Heuertz S, Odent T, Munnich A, et al. (2007) Human immortalized chondrocytes carrying heterozygous FGFR3 mutations: an in vitro model to study chondrodysplasias. FEBS Lett 581: 2593-2598.
69. Gibbs L, Legeai-Mallet L (2007) FGFR3 intracellular mutations induce tyrosine phosphorylation in the Golgi and defective glycosylation. Biochim Biophys Acta 1773: 502-512.